The Complete Guide to NAD+ Dosing: How Much, How Often, and Why It Matters

NAD+ dosing is one of the most commonly misunderstood aspects of NAD+ therapy. People ask: how much do I need? How often should I inject? Is more always better? What happens if I miss a dose? The answers depend on the delivery method, your biological context, and the goals of your protocol.

This guide provides a clear, evidence-informed framework for NAD+ dosing via subcutaneous injection — the method used by the NADvance pen — and explains the pharmacological rationale behind each element of the protocol.

3 days Loading phase duration

48 hrs Maintenance interval

<2 min Time per injection

1000mg NADvance pen dose

 

Why Dosing Varies by Delivery Method

Before addressing specific doses, it is important to understand that NAD+ dosing cannot be discussed independently of delivery method. The dose required to achieve a given plasma NAD+ level varies enormously between oral supplementation and injectable routes:

•       Oral NMN at 500mg produces a modest, variable increase in whole-blood NAD+. Many individuals require 1,000–2,000mg daily for consistent results — and even then, absorption remains unpredictable.

•       Subcutaneous NAD+ achieves reliably higher plasma levels at comparable doses — because 100% of the dose reaches circulation without digestive degradation or hepatic first-pass metabolism.

This guide focuses specifically on subcutaneous dosing as used with the NADvance pen.

The NADvance pen delivers 1000mg pharmaceutical-grade NAD+ per pen, manufactured in MHRA-approved, GMP-certified facilities. Full pen details at nadvance.eu/pages/pen.

The Two-Phase Protocol: Loading and Maintenance

Phase 1: The Loading Protocol (Days 1–3)

The loading phase is designed to rapidly elevate plasma NAD+ from a depleted baseline to the therapeutic range — rather than approaching it gradually over weeks. This front-loads the therapeutic benefit and establishes the cellular environment from which maintenance dosing sustains elevated levels.

•       Duration: 3 consecutive days

•       Frequency: One injection per day

•       Timing: Morning administration is recommended, consistent with the natural NAD+ circadian rhythm

•       Purpose: Rapid plasma NAD+ elevation to therapeutic concentrations

The loading phase mirrors the approach used in IV NAD+ clinical protocols, where an initial intensive phase is always followed by a maintenance schedule — adapted here for subcutaneous delivery.

Phase 2: The Maintenance Protocol (Day 4 onwards)

Once the loading phase has established elevated plasma NAD+ levels, the maintenance protocol sustains them through regular, lower-frequency dosing:

•       Frequency: One injection every other day (every 48 hours)

•       Timing: Morning administration preferred

•       Duration: Ongoing — NAD+ therapy is a continuous maintenance strategy, not a finite course

The every-other-day frequency is pharmacokinetically rational. Subcutaneous NAD+ achieves peak plasma levels within 1–4 hours and maintains elevated levels for approximately 24–48 hours, after which levels begin to decline. Every-other-day dosing maintains a consistently elevated baseline without accumulation risk.

Why the Loading Phase Matters

Skipping or shortening the loading phase is one of the most common protocol errors among new NAD+ users, and it significantly delays the onset of felt benefits. Consider the analogy of filling a depleted reservoir: if you add water slowly, it takes far longer to reach a useful level than if you fill rapidly at the start and then maintain the level through regular smaller additions.

Users who complete the full loading protocol consistently report earlier onset of noticeable benefits — particularly improved morning energy and reduced afternoon fatigue — than those who begin directly with every-other-day dosing.

Factors That Influence Your Optimal Dose Response

Age

Older adults typically have more severely depleted NAD+ and less efficient endogenous production via the NAMPT pathway. This means the cellular demand for exogenous NAD+ is higher, and the loading phase is particularly important to ensure rapid establishment of therapeutic levels.

Lifestyle and Stress

High stress, poor sleep, alcohol consumption, and intense exercise training all increase NAD+ consumption beyond normal resting rates. In individuals with these higher-demand contexts, maintaining strict adherence to the every-other-day protocol is especially important to prevent plasma levels from declining between doses.

Baseline NAD+ Status

Individuals with severely depleted baseline NAD+ — common in those over 50, those with chronic fatigue, and those with high-stress lifestyles — often experience the most noticeable early response to the loading protocol. The lower your baseline, the more dramatic the initial restoration effect.

Timing: When in the Day Should You Inject?

Morning administration is the evidence-supported recommendation for three reasons:

•       NAD+ biosynthesis follows a circadian rhythm governed by NAMPT expression — this enzyme is most active during the light phase, and morning administration aligns with this natural rhythm.

•       The energy-promoting effects of elevated NAD+ are most useful experienced during the active day, not during sleep when energy demands are lower.

•       Morning injection integrates most easily into a consistent daily routine, supporting the adherence that determines long-term protocol outcomes.

What Happens If You Miss a Dose?

Missing an occasional maintenance dose is not a protocol failure, but it does allow plasma NAD+ to decline from its maintained level. The appropriate response:

•       Do not double-dose to compensate — simply resume with your next scheduled injection.

•       If you miss two or more consecutive doses, consider a 2-day mini-loading phase (daily injections) before returning to every-other-day maintenance to re-establish optimal levels more quickly.

For protocol questions specific to the NADvance pen, our FAQ at nadvance.eu/pages/faq covers dosing questions in detail. Full instructions at nadvance.eu/pages/instructions.

Long-Term Dosing: Is Ongoing Use Safe?

NAD+ is an endogenous molecule — your body produces and uses it constantly. There is no published evidence of NAD+ accumulation toxicity or adverse effects from long-term therapeutic use. All published human trials to date report a consistently excellent safety profile. The intention of NAD+ therapy is ongoing cellular maintenance — the benefits are sustained through consistent use and may decline if the protocol is discontinued for extended periods.

Protocol Element	Recommendation	Scientific Rationale
Loading duration	3 consecutive days	Rapid plasma NAD+ elevation to therapeutic range
Loading frequency	Once daily	Maximises initial plasma concentration
Maintenance frequency	Every other day	Matches 24–48hr plasma half-life of subcutaneous NAD+
Injection timing	Morning	Aligns with circadian NAMPT rhythm
Long-term use	Ongoing	NAD+ continuously consumed; benefits require sustained levels
Missed dose	Skip and continue	No double-dosing; no accumulation risk

 

Frequently Asked Questions

Q: How much NAD+ should I inject per dose? A: The NADvance pen is pre-dosed at 1000mg per pen, calibrated for the standard subcutaneous loading and maintenance protocol. This dose is designed to achieve therapeutic plasma NAD+ levels via subcutaneous delivery without excess. Individual adjustments beyond the standard protocol should be discussed with a healthcare professional.

 

Q: How often do I need to inject NAD+? A: After the initial 3-day daily loading phase, the NADvance maintenance protocol calls for one injection every other day. This frequency matches the pharmacokinetic profile of subcutaneous NAD+ delivery, maintaining consistently elevated plasma levels.

 

Q: Can I inject more often for faster results? A: The every-other-day maintenance protocol is designed to maintain optimal plasma NAD+ levels. Injecting more frequently during maintenance is unlikely to produce additional benefit and is not supported by current evidence. The loading phase already achieves rapid elevation; patience with the maintenance protocol is what drives cumulative results.

 

Q: What time of day should I inject NAD+? A: Morning administration is recommended, consistent with the natural circadian rhythm of NAD+ biosynthesis. Morning dosing aligns the therapeutic peak with the most energy-demanding part of your day and is most easily integrated into a consistent daily routine.

Ready to begin your protocol? Order the NADvance pen at nadvance.eu/products/nadvance-pen-1000mg and follow our detailed dosing guide at nadvance.eu/pages/instructions.